RadNet`s DeepHealth acquires iCAD in full
17 Jul 2025 //
GLOBENEWSWIRE
iCAD`s Proposed Acquisition by RadNet Backed by ISS, Glass Lewis
08 Jul 2025 //
GLOBENEWSWIRE
iCAD Reports Q1 2025 Financial Results
13 May 2025 //
GLOBENEWSWIRE
iCAD, Microsoft Team Up for Mammography Access via PIN
29 Apr 2025 //
GLOBENEWSWIRE
RadNet to Acquire iCAD for Breast Cancer Detection
15 Apr 2025 //
GLOBENEWSWIRE
iCAD Appoints Mark Koeniguer as Chief Commercial Officer
08 Apr 2025 //
GLOBENEWSWIRE
iCAD Reports Q4 & Full-Year 2024 Financial Results
19 Mar 2025 //
GLOBENEWSWIRE
iCAD to Report Q4 and Full Year 2024 Results on March 19, 2025
11 Mar 2025 //
GLOBENEWSWIRE
iCAD and RamSoft Partner to Deliver ProFound AI Mammography Solut
05 Mar 2025 //
GLOBENEWSWIRE
Koios Medical, iCAD Partner to Expand AI Breast Cancer Solutions
26 Feb 2025 //
GLOBENEWSWIRE
iCAD To Present Five AI-Powered Studies On Breast Cancer At ECR 2025
19 Feb 2025 //
GLOBENEWSWIRE
iCAD Pre-Announces Estimated Q4 2024 Revenue
27 Jan 2025 //
GLOBENEWSWIRE
iCAD’s AI-Risk Detection for BAC Assessed Across Populations
11 Dec 2024 //
GLOBENEWSWIRE
iCAD Advances Breast Cancer Fight with AI Solutions at RSNA 2024
04 Dec 2024 //
GLOBENEWSWIRE
Archstone Foundation Names Rigo J. Saborio as New CEO
26 Nov 2024 //
GLOBENEWSWIRE
iCAD Reports Financial Results for Q3 Ended September 30, 2024
13 Nov 2024 //
GLOBENEWSWIRE
iCAD`s ProFound Detection Version 4.0 Gains FDA Clearance
12 Nov 2024 //
GLOBENEWSWIRE
iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference
06 Nov 2024 //
GLOBENEWSWIRE
iCAD to Report Q3 2024 Financial Results on Nov 13, 2024
05 Nov 2024 //
GLOBENEWSWIRE
iCAD Shows ProFound Cloud Growth At JFR 2024
03 Oct 2024 //
GLOBENEWSWIRE
iCAD to Participate in the iAccess Alpha Buyside Best Ideas Fall Conference 2024
11 Sep 2024 //
GLOBENEWSWIRE
iCAD Reports Financial Results for Second Quarter Ended June 30, 2024
13 Aug 2024 //
GLOBENEWSWIRE
iCAD to Report Second Quarter 2024 Financial Results on August 13, 2024
06 Aug 2024 //
GLOBENEWSWIRE
ICAD And Windsong Partner To Implement AI-Powered Mammography
29 Jul 2024 //
GLOBENEWSWIRE
iCAD Highlight Research on Potential of its AI Algorithm on Breast Cancer Risk
26 Jun 2024 //
GLOBENEWSWIRE
iCAD to Participate in the MedInvest MedTech, AI & Digital Health Conference
04 Jun 2024 //
GLOBENEWSWIRE
iCAD Reports Financial Results for First Quarter Ended March 31, 2024
15 May 2024 //
GLOBENEWSWIRE
UPDATE - iCAD to Report First Quarter 2024 Financial Results on May 15, 2024
08 May 2024 //
GLOBENEWSWIRE
iCAD to Report First Quarter 2024 Financial Results on May 15, 2024
02 May 2024 //
GLOBENEWSWIRE
iCAD, Densitas Partner for Enhanced Breast Health
09 Apr 2024 //
GLOBENEWSWIRE
iCAD`s AI Suite Uncovers Hidden Heart Disease Risk According to New Data
08 Apr 2024 //
GLOBENEWSWIRE
iCAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI
03 Apr 2024 //
GLOBENEWSWIRE
iCAD Unveils ProFound Cloud, Enabling Interoperability & Access to Breast AI Sol
02 Apr 2024 //
GLOBENEWSWIRE
iCAD Releases Enhanced ProFound Detection Workstation Features
19 Mar 2024 //
GLOBENEWSWIRE
iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results
12 Mar 2024 //
GLOBENEWSWIRE
iCAD Highlights Data Showing Ability to Reduce Breast Interval Cancer Rates
28 Feb 2024 //
GLOBENEWSWIRE
iCAD to Report Fourth Quarter and Full Year 2023 Financial Results
27 Feb 2024 //
GLOBENEWSWIRE
iCAD expands appointed Dr. Hedvig Hricak, MD, PhD, (Dr.h.cáµ)
27 Feb 2024 //
GLOBENEWSWIRE
iCAD to Participate in the BTIG at Snowbird
06 Feb 2024 //
GLOBENEWSWIRE
iCAD Expands Board of Directors with Appointment of Michael J. Doyle
30 Jan 2024 //
GLOBENEWSWIRE
iCAD Expands Executive Sales Leadership Team as Business Grows
18 Dec 2023 //
GLOBENEWSWIRE
iCAD`s AI-powered solutions to Help Accelerate Breast Cancer Detection
28 Nov 2023 //
GLOBENEWSWIRE
iCAD and CancerIQ Announce Partnership to Integrate AI-Enabled Technology
20 Nov 2023 //
GLOBENEWSWIRE
iCAD to Participate in the 14th Annual Craig-Hallum Alpha Select Conference
14 Nov 2023 //
GLOBENEWSWIRE
iCAD Reports Financial Results for Third Quarter Ended September 30, 2023
13 Nov 2023 //
GLOBENEWSWIRE
iCAD to Report Third Quarter 2023 Financial Results on November 13, 2023
30 Oct 2023 //
GLOBENEWSWIRE
iCAD, Inc. Announces Sale of Xoft, its Brachytherapy Business Line, to Elekta
23 Oct 2023 //
GLOBENEWSWIRE
Health Canada Grants Device License for iCAD`s ProFound Risk 2.0
16 Aug 2023 //
GLOBENEWSWIRE
iCAD and Google Health Expand Integration of Google™s AI Technology
14 Aug 2023 //
GLOBENEWSWIRE
iCAD Reports Financial Results for Second Quarter Ended June 30, 2023
14 Aug 2023 //
GLOBENEWSWIRE
iCAD to Report Second Quarter 2023 Financial Results on August 14, 2023
31 Jul 2023 //
GLOBENEWSWIRE
iCAD Signs Strategic Commercial Agreement with Radiology Partners
18 Jul 2023 //
GLOBENEWSWIRE
iCADs ProFound Insights, ProFound Impact Webinar Series to Feature Cleveland
12 Jul 2023 //
GLOBENEWSWIRE
iCAD Offers ROI Analysis Based on Results from its ProFound Breast AI Suite
10 Jul 2023 //
GLOBENEWSWIRE
iCAD ProFound AI Breast Suite Wins Healthcare Challenge Award
18 May 2023 //
GLOBENEWSWIRE
iCAD Reports Financial Results for First Quarter Ended March 31, 2023
15 May 2023 //
GLOBENEWSWIRE
Long-Term Research Confirms Xoft Skin eBx is as Safe as Mohs Surgery
11 May 2023 //
GLOBENEWSWIRE
iCAD Showcases Breast AI Suite at Society of Breast Imaging Symposium, World
03 May 2023 //
GLOBENEWSWIRE
iCAD to Report First Quarter 2023 Financial Results on May 15, 2023
01 May 2023 //
GLOBENEWSWIRE
New and Real-World Clinical Confirms ProFound AI Increases Cancer Detection
20 Apr 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support